GlassScriptPhysician profile
Harsh Patel
NPI 1831333566
$11,649.32
in general payments reported to CMS, 2019-2025
47 companies · $1,275 in 2025
The $1,275 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,098 · 2020: $1,075 · 2021: $1,110 · 2022: $1,927 · 2023: $1,189 · 2024: $974 · 2025: $1,275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,074 · Travel and Lodging: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,074.27 |
| Travel and Lodging | $363.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $1,583.59 | 2019-2025 | Biomonitor, Amvia Edge |
| Abbott Laboratories | $1,392.01 | 2019-2025 | Navitor, Mitraclip, Cardiomems |
| Medtronic, INC. | $1,135.92 | 2021-2025 | Hawkone, Abre, Linq II |
| Boston Scientific Corporation | $1,028.63 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Watchman Access System |
| Silk Road Medical, INC. | $860.30 | 2019 | |
| Amgen INC. | $835.19 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $406.12 | 2019-2025 | |
| Philips North America LLC | $379.26 | 2020-2024 | (Cm9) Amb Mon & Diag Und, (5091) Amb Mon & Diag Und |
| Janssen Pharmaceuticals, INC | $350.61 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $339.52 | 2019-2025 | Lifevest |
| Edwards Lifesciences Corporation | $331.93 | 2019-2023 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $293.12 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $274.85 | 2019-2025 | |
| Shockwave Medical, INC | $228.14 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $222.89 | 2021-2025 | Verquvo, Steglatro |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $179.47 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $175.59 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $135.56 | 2019-2024 | Farxiga |
| Amarin Pharma, INC. | $128.41 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $119.02 | 2019 | |
| Cvrx, INC. | $113.87 | 2023-2024 | Barostim Neo System |
| W. L. Gore & Associates, INC. | $112.54 | 2020-2023 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Angiodynamics, INC. | $97.79 | 2019-2022 | |
| Nuwellis, INC. | $81.59 | 2020-2021 | |
| Penumbra, INC. | $80.01 | 2022-2024 | Indigo System |
| Esperion Therapeutics, INC. | $72.69 | 2021-2024 | Nexletol |
| Kowa Pharmaceuticals America, INC. | $69.82 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.28 | 2022-2023 | |
| Genentech USA, INC. | $61.98 | 2019-2020 | |
| Bridgebio Pharma, INC. | $59.45 | 2025 | Attruby |
| Cardiva Medical, INC. | $57.58 | 2024-2025 | Optowire, Savvywire |
| Lundbeck LLC | $55.64 | 2019 | |
| Novo Nordisk INC | $44.57 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Kiniksa Pharmaceuticals International, Plc | $28.36 | 2024 | Arcalyst |
| Chiesi USA, INC. | $26.25 | 2019-2020 | |
| Abbvie INC. | $24.46 | 2022 | |
| Portola Pharmaceuticals, LLC | $24.40 | 2019 | |
| Biosense Webster, INC. | $21.74 | 2019 | |
| Abiomed | $20.73 | 2024 | Impella |
| Allergan, INC. | $18.62 | 2020 | |
| Cook Medical LLC | $18.61 | 2019 | |
| Olympus America INC. | $17.58 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $15.91 | 2023 | Inpefa |
| Arbor Pharmaceuticals, INC. | $15.03 | 2020 | |
| Inari Medical, INC. | $14.69 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $14.59 | 2020 | |
| Medtronic Vascular, INC. | $14.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harsh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.